Int J Ophthalmol
September 2023
Aim: To conduct a classification study of high myopic maculopathy (HMM) using limited datasets, including tessellated fundus, diffuse chorioretinal atrophy, patchy chorioretinal atrophy, and macular atrophy, and minimize annotation costs, and to optimize the ALFA-Mix active learning algorithm and apply it to HMM classification.
Methods: The optimized ALFA-Mix algorithm (ALFA-Mix+) was compared with five algorithms, including ALFA-Mix. Four models, including ResNet18, were established.
This study aims to implement and investigate the application of a special intelligent diagnostic system based on deep learning in the diagnosis of pterygium using anterior segment photographs. A total of 1,220 anterior segment photographs of normal eyes and pterygium patients were collected for training (using 750 images) and testing (using 470 images) to develop an intelligent pterygium diagnostic model. The images were classified into three categories by the experts and the intelligent pterygium diagnosis system: (i) the normal group, (ii) the observation group of pterygium, and (iii) the operation group of pterygium.
View Article and Find Full Text PDFBackground: In the development of artificial intelligence in ophthalmology, the ophthalmic AI-related recognition issues are prominent, but there is a lack of research into people's familiarity with and their attitudes toward ophthalmic AI. This survey aims to assess medical workers' and other professional technicians' familiarity with, attitudes toward, and concerns about AI in ophthalmology.
Methods: This is a cross-sectional study design study.
Transl Vis Sci Technol
June 2021
Introduction: In April 2018, the US Food and Drug Administration (FDA) approved the world's first artificial intelligence (AI) medical device for detecting diabetic retinopathy (DR), the IDx-DR. However, there is a lack of evaluation systems for DR intelligent diagnostic technology.
Methods: Five hundred color fundus photographs of diabetic patients were selected.